November 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 01, 2025
The induced pluripotent stem cells production market size is calculated at $1.82 bn in 2025 is to hit $4.11 bn by 2034. The iPSC production market is advancing rapidly. GC Therapeutics raised $75M to develop "supercell" drugs, while FUJIFILM invested $200M in expanding facilities for iPSC and biologics. AI integration, using ML and DL, enhances iPS...
November 01, 2025
Market insights predict the global non-alcoholic steatohepatitis treatment industry will increase from USD 7.75 billion in 2024 to USD 92.5billion by 2034, achieving a CAGR of 28.14%. North America led the global non-alcoholic steatohepatitis (NASH) treatment market with 79% share in 2024. The rising prevalence of obesity, growing research and...
November 01, 2025
According to market projections, the cancer stem cells sector is expected to grow from USD 3.2 billion in 2024 to USD 8.04 billion by 2034, reflecting a CAGR of 9.64%. Stem cell-based therapies are highly useful in providing high-quality treatment, due to which stem cells are being continuously grown and studied to treat various cancers....
November 01, 2025
The food allergy treatment market size is calculated at $7.47 bn in 2025 is to hit $15.32 bn by 2034. In 2024, notable advancements in food allergy treatment include Mitsubishi Gas Chemical's partnership with Alerje to enhance global allergy care, the U.S. FDA's approval of Xolair for severe allergies, and Inimmune's collaboration with Intrommune t...
November 01, 2025
The organ transplant immunosuppressant drugs market size is calculated at $5.81 bn in 2025 is to hit $8.82 bn by 2034. In 2024, Eledon Pharmaceuticals showed positive trial results for tegoprubart in islet transplant recipients with type 1 diabetes. Duke Children’s Hospital launched a trial on new anti-rejection medications in children. Astel...
November 01, 2025
The enzyme replacement therapy market size is calculated at $11.34 bn in 2025 is to hit $24.71 bn by 2034. In January 2025, Denali Therapeutics received FDA Breakthrough Therapy Designation for DNL310 (tividenofusp alfa) for Hunter syndrome. In July 2024, GC Biopharma’s GC1130A got fast-track status for Sanfilippo syndrome type A. In December...
November 01, 2025
The allergy immunotherapy market size is calculated at $2.12 bn in 2025 is to hit $4.50 bn by 2034. In 2024, Europe led the allergy immunotherapy market share of 68%, with subcutaneous immunotherapy dominating treatment types. The tablets segment held the largest market share, while the drops segment is expected to grow significantly. The allergy r...
November 01, 2025
According to market projections, the inhalation anesthesia sector is expected to grow from USD 1.64 billion in 2025 to USD 2.94 billion by 2034. In 2024, North America led the inhalation anesthesia market (53% share), with Asia-Pacific poised for rapid growth. Sevoflurane dominated by drug, while desflurane shows promising growth. Maintenance appli...
November 01, 2025
According to market projections, the radiation therapy sector is expected to grow from USD 7.86 billion in 2025 to USD 12.93 billion by 2034. In 2024, key investments boosted cancer treatment innovation: £2.94M to RadNet Leeds for radiation research, £70M for new radiation equipment after lobbying by Radiation UK, and £1.5B for su...
November 01, 2025
According to market projections, the hyperlipidemia drugs sector is expected to grow from USD 24.47 billion in 2025 to USD 31.49 billion by 2034, reflecting a CAGR of 2.84%. In 2024, North America led the global hyperlipidemia drugs market, with statins dominating by drug class. The Asia-Pacific region is expected to grow fastest. Oral administrati...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com